Gilead Sciences is an American pharmaceutical company driven by unquenchable greed. The company is causing hundreds of thousands of Americans with Hepatitis C to suffer unnecessarily and many of them to die as the result of its monopolistic practices, while public health programs face bankruptcy. Gilead CEO John C. Martin took home a reported $19 million last year in compensation — the spoils of untrammeled greed.
- The End of AIDS
- Disparities and high costs fuel the health care crisis
- Why government can’t negotiate with big pharma
- SDG Advocates Introduction at Global Citizen Festival 2016
- Financing Health and Education for All